Form D · Pharmaceuticals
ENCLARA HEALTH LLC
West Deptford, NJ · CIK 0001425666
Offering snapshot reported Apr 6, 2010 · SEC filing
- Reported sold
- $2.02M Offering amount: $3M
- Investors reported
- 55 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Mar 26, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2010 | Initial | $2,021,005 | No comparison | 55 | SEC filing |
| Apr 17, 2009 | Initial | $2,045,078 | No comparison | Not reported | SEC filing |
| Jan 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-114199
DEBT INSTRUMENTS THAT ARE CONVERTIBLE INTO EQUITY.
Source: Form D, filed Apr 6, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Horowitz | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1480 Imperial Way
West Deptford, NJ, 08066
West Deptford, NJ, 08066